Tag: Import Substitution

A new facility for blood plasma medicines will be established in St. Petersburg

On March 23, Noroorlovskaya Special Economic Zone in St. Petersburg will host an official ceremony marking the launch of construction of IMMUNO-GEM, a production facility for human blood plasma-derived medicines.

Kaluga is expected to complete its program for radiopharmaceuticals in two years

radiopharmaceutical drug
Kaluga pharmaceutical cluster recently increased the number of locally manufactured drugs from 65 to 154. The Governor expects that the region needs 2 years to complete its import substitution program for radiopharmaceuticals.

Russia plans to lift its ban on commercial cultivation of opium poppy

The Russian Ministry of Industry and Trade submitted to the government a draft law allowing cultivation of narcotic plants for pharmaceutical industry. This includes the opium poppy, which is used to manufacture painkillers.

Import substitution leads to growth of drug manufacturing in Russia

Drug Manufacturing
According to Rosstat, in 2017, the output of medicines was 12.3% higher than in 2016. The Russian Ministry of Industry and Trade said that output growth was facilitated by state support to Russian manufacturers.

Pharmstandard-Leksredstva will complete its project on asthma drugs in 2018

In 2018, Pharmstandard-Leksredstva, a drug manufacturer, will launch the production of Russian-made medicines for asthma patients, announced the press office of the Kursk region administration. The pr...

Dalkhimpharm develops the manufacturing of import-substituting medicines

The specialists of Dalkhimpharm JSC are gaining the experience in manufacturing of new drugs under the import substitution program. The R&D portfolio of the plant includes now seven new medicines ...

NPO Microgen launches a production area for botulinum toxins

NPO Microgen, a subsidiary of Nacimbio holding company of Rostec Corporation, is launching a new modern production area to manufacture Relatox, the only Russian botulinum toxin type A

A pharmaceutical plant is scheduled for construction in Chelyabinsk region

The investors from Yekaterinburg plan to establish a pharmaceutical plant in Chelyabinsk region. The project participants began the negotiations with international suppliers of substances.

Russian scientists receive award for unique R&D in the area of oncology

The award of the Government of the Russian Federation was given for the development, manufacturing and implementation of Russian radioactive sources for contact radiation therapy

New import substitution project of Medsintez is at its final stage

The specialists at Medsintez plant produced a test batch of injection pens with a drug used for in vitro fertilization

New Pharmasyntez plant will produce 30 types of hormonal drugs

About 30 types of hormonal drugs will be manufactured at the new plant in Tyumen region

Kurgan-based Sintez launches 4 new plastic blood bags to the market

blood bag
Sintez has received the registration certificates for four types of plastic bags for the blood and its components

Russian pharma companies are registering medicines in more than 60 countries

When Pharma-2020 was launched in 2010, its first priority was to provide domestically manufactured medicines

About 0.5 trillion rubles are allocated for procurement of VED drugs in Russia

Notwithstanding the market economy, the state must constantly monitor the prices of medicines, because this issue concerns everyone who lives in Russia

Nacimbio will invest 2.2 billion rubles in vaccine manufacturing

The Governor of the Ryazan region and the President of FORT LLC have signed an agreement to extend the provision of state support

Russian pharmaceutical industry strives for new achievements

The 7th International Partnering Forum "Life Sciences Invest. Partnering Russia" set the ways for further development of the industry